All In Biotech

Free tool

FAERS Monitor: Tysabri

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125104 or its brand name (Tysabri, Natalizumab). Reports on generic versions are filed under their own applications.

Reports

181,255

Serious

56,644

31% of reports

Hospitalization

34,723

Death reported

5,131

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue19,632
  • multiple sclerosis relapse16,953
  • headache10,010
  • multiple sclerosis9,821
  • gait disturbance9,507
  • fall8,050
  • asthenia8,012
  • memory impairment7,972
  • malaise7,449
  • drug ineffective6,917
  • urinary tract infection6,323
  • pain5,988
  • balance disorder5,695
  • hypoaesthesia5,437
  • pain in extremity4,942

Reports by year received

View as table
YearReports
20042
20051,355
200648
2007559
20081,549
20092,555
201020,069
201125,662
201222,980
201329,497
201412,502
20157,069
20168,948
20178,570
20188,295
20196,205
20205,145
20213,964
20224,362
20233,971
20243,274
20252,831
20261,843

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,872,904 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple sclerosis relapseSignal16,95337.837.2458,695
multiple sclerosisSignal9,82129.729.1217,179
balance disorderSignal5,6958.17.933,311
memory impairmentSignal7,9727.16.939,509
gait disturbanceSignal9,5076.05.938,098
urinary tract infectionSignal6,3234.44.316,290
hypoaesthesiaSignal5,4374.34.213,542
fatigueSignal19,6323.02.926,069
fallSignal8,0502.92.89,593
astheniaSignal8,0122.52.57,215
malaise7,4492.01.93,669
pain in extremity4,9422.01.92,325
headache10,0101.91.84,083
pain5,9881.11.195
drug ineffective6,9170.60.61,868

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.